COVAXX to Participate in Opening Keynote Panel with FDA and WHO experts on SARS-CoV-2 at the World Vaccine & Immunotherapy Conference West Coast December 1, 2020
- Written by Newsfile
Hauppauge, New York--(Newsfile Corp. - November 30, 2020) - COVAXX, a U.S. company developing a synthetic multitope peptide-based vaccine to fight COVID-19, today announced that Chief Scientific Officer, Farshad Guirakhoo, Ph.D. will participate in the Opening Keynote panel discussion, "SARS-CoV-2 - We have a vaccine-what now?" at the...